IL17A and ankylosis: The preferential alleviation of spinal inflammation and ankylosis with IL-17A blockade in AS patients convincingly suggests that IL-17, not IL-23, is the major cytokine directing disease pathogenesis at least in axial SpA and that it is likely to be generated in an IL-23-independent manner.